Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2019 Earnings Conference Call May 9, 2019 11:30 AM ET
Company Participants
Wade Walke - VP, IR
Stanley Crooke - Founder, Chairman, CEO & President
Elizabeth Hougen - SVP, Finance & CFO
Brett Monia - Founder, COO, SVP, Translational Medicine & Director
Frank Bennett - SVP, Antisense Research
Conference Call Participants
Chad Messer - Needham & Company
Benjamin Burnett - Stifel, Nicolaus & Company
Rick Bienkowski - SVB Leerink
David Lebowitz - Morgan Stanley
Yanan Zhu - Wells Fargo Securities
Ritu Baral - Cowen and Company
Eliana Merle - Cantor Fitzgerald & Co.
Jessica Fye - JPMorgan Chase & Co.
I-Eh Jen - Laidlaw & Company
Operator
Good morning and welcome to the Ionis Pharmaceuticals Q1 2019 Financial Results Conference Call. As a reminder, this call is being recorded.
At this time, I would like to turn the call over to Wade Walke, Vice President, Investor Relations, to lead off the call. Please begin.
Wade Walke
Thank you, Gary. Before we begin, I encourage everyone to go to the Investor section of Ionis website to find the press release and related financial tables, including a reconciliation of the GAAP to non-GAAP financial measures that we will discuss today. We believe non-GAAP financial results better represent the economics of our business and how we manage our business.
We've also posted slides on our website that accompany our discussion today. With me on the call are Stan Crow, Chairman of the Board and Chief Executive Officer; Beth Hougen, Chief Financial Officer; Brett Monia, Chief Operating Officer; and joining us for Q&A will be Damien McDevitt, Chief Business Officer; and Frank Bennett, Senior Vice President of Research. I would like to draw your attention to Slide 3, which contains our forward-looking luggage statement. We'll begin - we will be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject
- Read more current IONS analysis and news
- View all earnings call transcripts